1 s2.0 S0891584903005379 Main
1 s2.0 S0891584903005379 Main
1 s2.0 S0891584903005379 Main
doi:10.1016/j.freeradbiomed.2003.08.001
Original Contribution
EFFECT OF CIGARETTE SMOKE ON ORAL PEROXIDASE ACTIVITY IN
HUMAN SALIVA: ROLE OF HYDROGEN CYANIDE
IFAT KLEIN,* RAFAEL M. NAGLER,*, RUTH TOFFLER,* ALBERT
VAN
DER VLIET,
and
ABRAHAM Z. REZNICK*
*Department of Anatomy and Cell Biology, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa,
Israel; Laboratory of Oral Biochemistry, Rambam Medical Center, Haifa, Israel; and Department of Pathology, University of
Vermont, Burlington, VT, USA
(Received 16 May 2003; Revised 12 August 2003; Accepted 14 August 2003)
AbstractPeroxidase activity in human saliva is composed of salivary peroxidase (80%), of salivary glandular origin,
and myeloperoxidase (20%), of leukocyte origin. The term oral peroxidase (OPO) is used here to denote the total
activity of both peroxidase species. Using the 2-nitrobenzoic acid-thiocyanate assay, OPO activity was measured in the
saliva of nonsmokers after exposure to gas-phase cigarette smoke (CS) in an in vitro system using three puffs of CS in
1 h. A marked decrease of 76% of activity was observed following three puffs of CS. In order to elucidate the
mechanism by which CS caused loss of OPO activity, several oxidants and antioxidants were applied to saliva in vitro
in the presence and absence of CS. No protection for CS-induced loss of OPO activity occurred in the presence of
glutathione, N-acetylcysteine, ascorbic acid, or Desferal. Exposure of saliva to purified aldehydes present in CS did not
significantly affect OPO loss of activity. Similarly, ascorbic acid in the presence of FeCl3 and nicotine also had no effect
on OPO activity. Exposure of OPO to cyanate at levels present in CS caused a 6570% loss of OPO activity, which was
reversible after 24 h of dialysis. Moreover, hydroxocobalamin, a known cyanate chelator, could prevent CS- and
potassium cyanide-induced inactivation of OPO by 70 90%. The results show that hydrogen cyanide, known to be
present in microgram amounts per cigarette, is likely to be the species in CS responsible for loss of salivary OPO
activity. The finding of reduced salivary OPO levels after CS exposure may represent a contributory mechanism for
CS-related compromises in antimicrobial defenses in the aerodigestive tract. 2003 Elsevier Inc.
KeywordsCigarette smoke, Hydrogen cyanide, Hydroxocobalamin, Oral peroxidase, Free radicals
INTRODUCTION
Cigarettes
The cigarettes used in this study were popular commercial cigarettes (Time cigarettes; Dubek Ltd., Tel
Aviv, Israel) containing 14 mg of tar and 0.9 mg of
nicotine per cigarette.
Exposure of saliva to CS: in vitro study
In vitro study was carried out using Time cigarettes
combined with a vacuum system, as described previously
[11,12]. Saliva (4 5 ml) from consenting volunteers was
placed in 50 ml flasks with a sidearm to which the
cigarettes were attached. A reproducible vacuum was
created in the flask and, upon opening the vacuum, the
CS of the whole lighted cigarette was drawn into the
flask. Saliva samples for OPO analysis were drawn before smoking (zero time), and cigarettes were smoked at
intervals of 20 min. Saliva samples for OPO analysis
were drawn at 20 min intervals, prior to the next CS
exposure.
Peroxidase activity
OPO activity was measured according to the 2-nitrobenzoic acid-thiocyanate assay [2]. Briefly, in this assay
5,5-dithiobis, 2-nitrobenzoic acid (DTNB) is reduced to
2-nitrobenzoic acid (NBS) by the addition of -mercaptoethanol. The disappearance of 2-nitrobenzoic acid
while reacting with OSCN, the product of OPO, was
monitored at 412 nM at pH 5.6, as described previously
[3]. One unit of enzyme activity was defined as the level
of enzyme activity needed to cleave 1 mol of 2-nitrobenzoic acid/min at 22C using a molar extinction coefficient of 12,800 [2].
1449
Figure 1 shows the loss of OPO activity after exposure of saliva of four volunteers to three puffs of CS over
a 1 h time period. It can be seen that OPO activity was
decreased over time to about 22% of the control. The
initial mean SEM of the four volunteers was 708 52
mU/ml (n 4).
CS contains a number of constituents (e.g., oxidants,
aldehydes, cyanide) that can cause protein modifications
and influence protein enzyme activity. In order to elucidate which constituents could cause loss of OPO activity,
the saliva of several subjects was exposed to CS in the
presence of 1 mM GSH, Desferal, or ascorbic acid.
1450
I. KLEIN et al.
Fig. 2. Effect of antioxidants on oral peroxidase (OPO) activity exposed to cigarette smoke (CS). exposure to CS only;
exposure to CS 1 mM glutathione; exposure to CS 1 mM
Desferal; exposure to CS 1 mM ascorbate (n 3). Each point
represents the mean SD of saliva from three or four subjects.
1451
Fig. 7. Effect of addition of potassium cyanide (KCN) on oral peroxidase (OPO) activity and recovery after dialysis. Column 1 control
OPO activity at zero time; column 2 control OPO activity after
dialysis for 18 h without exposure to KCN; column 3 OPO activity
after exposure to 150 M KCN for 2 min with no dialysis; column 4
OPO activity of saliva exposed to KCN and dialysis for 18 h; column
5 saliva exposed to KCN after 18 h without dialysis. Results
represent the mean SD of four different experiments. *p .02;
**NS not significant.
DISCUSSION
1452
I. KLEIN et al.
REFERENCES
[1] Mandel, I. D. The role of saliva in maintaining oral homeostasis.
J. Am. Dent. Assoc. 119:298 304; 1989.
[2] Nagler, R. M.; Klein, I.; Zarzhevsky, N.; Drigues, N.; Reznick,
A. Z. Characterization of the differentiated antioxidant profile of
human saliva. Free Radic. Biol. Med. 32:268 277; 2002.
[3] Pruitt, K. M.; Kamau, D. N.; Miller, K.; Mansson-Rahemtulla, B.;
Rahemtulla, F. Quantitative, standardized assays for determining
the concentrations of bovine lactoperoxidase, human salivary
peroxidase, and human myeloperoxidase. Anal. Biochem. 191:
278 286; 1990.
[4] Toljanic, J. A.; Siddiqui, A. A.; Patterson, G. L.; Irwin, M. E. An
evaluation of a dentifrice containing salivary peroxidase elements
for the control of gingival disease in patients with irradiated head
and neck cancer. J. Prosthet. Dent. 76:292296; 1996.
[5] Grisham, M. B.; Ryan, E. M. Cytotoxic properties of salivary
oxidants. Am. J. Physiol. Cell Physiol. 258:C115C121; 1990.
[6] Guven, Y.; Satman, I.; Dinccag, N.; Alptekin, S. Salivary peroxidase activity in whole saliva of patients with insulin-dependent
(type-1) diabetes mellitus. J. Clin. Periodontol. 23:879 881;
1996.
[7] Aune, T. M.; Thomas, E. L. Accumulation of hypothiocyanite ion
during peroxidase-catalyzed oxidation of thiocyanate ion. Eur.
J. Biochem. 80:209 214; 1977.
[8] Reznick, A. Z.; Cross, C. E.; Hu, M.-L.; Suzuki, Y. J.; Khwaja, S.;
Safadi, A.; Motchnik, P. A.; Packer, L.; Halliwell, B. Modification of plasma proteins by cigarette smoke as measured by protein
carbonyl formation. Biochem. J. 286:607 611; 1992.
[9] Reznick, A. Z.; Han, D.; Packer, L. Cigarette smoke induced
oxidation of human plasma proteins, lipids, and antioxidants;
selective protection by the biothiols dihydrolipoic acid and glutathione. Redox Rep. 3:169 174; 1997.
[10] ONeill, C. A.; Halliwell, B.; van der Vliet, A.; Davis, P. A.;
Packer, L.; Tritschler, H.; Strohman, W. J.; Rieland, T.; Cross,
C. E.; Reznick, A. Z. Aldehyde-induced protein modifications in
human plasma: protection by glutathione and dihydrolipoic acid.
J. Lab. Clin. Med. 124:359 370; 1994.
[11] Nagler, R.; Lischinsky, S.; Diamond, E.; Drigues, N.; Klein, I.;
Reznick, A. Z. Effect of cigarette smoke on salivary proteins and
enzyme activities. Arch. Biochem. Biophys. 379:229 236; 2000.
[12] Nagler, R. M.; Lischinsky, S.; Diamond, E.; Klein, I.; Reznick,
A. Z. New insights into salivary lactate dehydrogenase of human
subjects. J. Lab. Clin. Med. 137:363369; 2001.
[13] Reznick, A. Z.; Klein, I.; Eiserich, J. P.; Cross, C. E.; Nagler,
R. M. Inhibition of oral peroxidase activity by cigarette smoke: in
vivo and in vitro studies. Free Radic. Biol. Med. 34:377384;
2003.
[14] Fowles, J.; Bates, M. The chemical constituents in cigarettes and
cigarette smoke: priorities for harm reduction. A report to the
New Zealand Ministry of Health; March, 2000:16.
ABBREVIATIONS
CN cyanide
CS cigarette smoke
GSH glutathione
KCNpotassium cyanide
LDHlactate dehydrogenase
MPOmyeloperoxidase
OH-CO hydroxocobalamin
OPO oral peroxidase
OSCN hypothiocyanite ion
SPOsalivary peroxidase